House dust mite allergy: Myths and realities;Allergie aux acariens: Mythes et réalités

Revue Medicale Suisse

Volumn 5, Issue 199, 2009, Pages 832-836

  Bouton, C ^a   Ducommun, J ^a  

^a Service d'immunologie et d'allergologie   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E ANTIBODY; LEUKOTRIENE RECEPTOR BLOCKING AGENT; THEOPHYLLINE;

ALLERGIC REACTION; ALLERGIC RHINITIS; ARTICLE; ASTHMA; ATOPIC DERMATITIS; DERMATOPHAGOIDES; DERMATOPHAGOIDES PTERONYSSINUS; HOUSE DUST ALLERGY; HUMAN; IMMUNOTHERAPY; MEDICAL LITERATURE; PATCH TEST; PRICK TEST; SKIN TEST; THERAPY EFFECT;

ADULT; ALLERGENS; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; ASTHMA; CHILD; CONJUNCTIVITIS, ALLERGIC; DERMATITIS, ATOPIC; DESENSITIZATION, IMMUNOLOGIC; DUST; HUMANS; HYPERSENSITIVITY; META-ANALYSIS AS TOPIC; PYROGLYPHIDAE; RHINITIS, ALLERGIC, PERENNIAL; TICK CONTROL;

EID: 65449169670     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Arlian LG, Platts-Mills TA. The biology of dust mites and the remediation of mite allergens in allergic disease.J Allergy Clin Immunol 2001; 107(Suppl.):S406-13.
2. Wutrich B. Epidemiology of allergies in Switzerland. Ther Umsch 2001;58:253-8.
3. Sheffer AL. Allergen avoidance to reduce asthma- related morbidity. N Engl J Med 2004;35I: 1134-6.
4. Eggleston PA, Bush R.K. Environmental allergen avoidance: An overview. J Allergy Clin Immunol 2001; 107(Suppl.):S403-5.
5. Weghofer M, Dall'Antonia Y, Grote M, et al. Characterization of Der p 21, a new important allergen derived from the gut of house dust mites. Allergy 2008;63:758- 67.
6. Akdis CA,Akdis M, Bieber T, et al. Diagnosis and treatment of atopic dermatitis in children and adults: European academy of allergology and clinical immunology/American academy of allergy. Asthma and immunology/PRACTALL Consensus report. Allergy 2006;61: 969-87.
7. Guler N, Kirerleri E,Tamay Z, et al. Atopy patch testing in children with asthma and rhinitis symptoms allergic to house dust mite. Pediatr Allergy Immunol 2006;17:346-50.
8. Wahn U, Lau S, Bergmann R, et al. Indoor allergen exposure is a risk factor for sensitization during the first three years of life. J Allergy Clin Immunol 1997;99:763-9.
9. Gøtzsche PC, Johansen HK. House dust mite control measures for asthma. Cochrane Database Syst Rev 2008;(2):CD001187.
10. Gøtzsche PC, Johansen HK. House dust mite control measures for asthma: Systematic review. Allergy 2008;63:646-59.
11. Sheikh A, Hurwitz B, Shehata Y. House dust mite avoidance measures for perennial allergic rhinitis. Cochrane Database Syst Rev 2007;(1):CD001563.
12. Dust-mite control measures of no use. Lancet 2008;371:1390.
13. Platts-Mills TA. Allergen avoidance in the treatment of asthma: Problems with the meta-analyses. J Allergy Clin Immunol 2008;122:694-6.
14. Fernández-Caldas E, Iraola V, Boquete M, et al. Mite immunotherapy. Curr Allergy Asthma Rep 2006; 6:413-9.
15. Bussmann C, Böckenhoff A, Henke H, et al. Does allergen-specific immunotherapy represent a therapeutic option for patients with atopic dermatitis ? J Allergy Clin Immunol 2006; 118:1292-8.
16. Nelson HS. Allergen immunotherapy: Where is it now? J Allergy Clin Immunol 2007;119:769-79.
17. Asero R. Lack of de novo sensitization to tropomyosin in a group of mite-allergic patients treated by house dust mite-specific immunotherapy. Int Arch Allergy Immunol 2005;137:62-5.
18. Lau S, llli S, Sommerfeld C, et al. Early exposure to house-dust mite and cat allergens and development of childhood asthma: A cohort study. Lancet 2000:356:1392-7.
19. Hide DW, Matthews S,Tariq S, et al. Allergen avoidance in infancy and allergy at 4 years of age. Allergy 1996;51:89-93.